{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:46:26Z","timestamp":1787499986777,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570442"],"award-info":[{"award-number":["81570442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00246-018-1818-7","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T22:57:59Z","timestamp":1518130679000},"page":"757-762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects"],"prefix":"10.1007","volume":"39","author":[{"given":"Qiangqiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,9]]},"reference":[{"key":"1818_CR1","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1183\/16000617.0067-2015","volume":"24","author":"IM Lang","year":"2015","unstructured":"Lang IM, Gaine SP (2015) Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension. Eur Respir Rev 24:630\u2013641","journal-title":"Eur Respir Rev"},{"key":"1818_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000354248","volume":"126","author":"KW Sung","year":"2013","unstructured":"Sung KW, Jeon YB, Kim NY, Park KY, Park CH, Choi CH et al (2013) The effects of perioperative inhaled iloprost on pulmonary hypertension with congenital heart disease. Cardiology 126:224\u2013229","journal-title":"Cardiology"},{"key":"1818_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2007.09.031","volume":"51","author":"DD Ivy","year":"2008","unstructured":"Ivy DD, Doran AK, Smith KJ, Mallory GB Jr, Beghetti M, Barst RJ et al (2008) Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. J Am Coll Cardiol 51:161\u2013169","journal-title":"J Am Coll Cardiol"},{"key":"1818_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5603\/CJ.2012.0062","volume":"19","author":"D Kenny","year":"2012","unstructured":"Kenny D, Hijazi ZM (2012) To inhale or to nebulize: treating the pulmonary vascular bed post-operatively in children with congenital heart disease. Cardiol J 19:335\u2013336","journal-title":"Cardiol J"},{"key":"1818_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ijcard.2010.04.093","volume":"147","author":"DZ Zhang","year":"2011","unstructured":"Zhang DZ, Zhu XY, Meng J, Xue HM, Sheng XT, Han XM et al (2011) Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension. Int J Cardiol 147:433\u2013437","journal-title":"Int J Cardiol"},{"key":"1818_CR6","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/01.CIR.103.4.544","volume":"103","author":"PC Rimensberger","year":"2001","unstructured":"Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B et al (2001) Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 103:544\u2013548","journal-title":"Circulation"},{"key":"1818_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa020204","volume":"347","author":"H Olschewski","year":"2002","unstructured":"Olschewski H, Simonneau G, Gali\u00e8 N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Sitbon O, Popov W, Ghofrani HA, Manes A, Kiely DG, Ewert R, Meyer A, Corris PA, Delcroix M, Gomez-Sanchez M, Siedentop H, Seeger W (2002) Aerosolized Iloprost Randomized Study Group.Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347:322\u2013329","journal-title":"N Engl J Med"},{"key":"1818_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ccd.21793","volume":"73","author":"A Limsuwan","year":"2009","unstructured":"Limsuwan A, Khosithseth A, Wanichkul S, Khowsathit P (2009) Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease. Catheter Cardiovasc Interv 73:98\u2013104","journal-title":"Catheter Cardiovasc Interv"},{"key":"1818_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000313864","volume":"116","author":"M Gorenflo","year":"2010","unstructured":"Gorenflo M, Gu H, Xu Z (2010) Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease. Cardiology 116:10\u201317","journal-title":"Cardiology"},{"key":"1818_CR10","doi-asserted-by":"crossref","first-page":"I76","DOI":"10.1161\/01.cir.0000032875.55215.cb","volume":"106","author":"DT Balzer","year":"2002","unstructured":"Balzer DT, Kort HW, Day RW, Corneli HM, Kovalchin JP, Cannon BC, Kaine SF, Ivy DD, Webber SA, Rothman A, Ross RD, Aggarwal S, Takahashi M, Waldman JD (2002) Inhaled nitric oxide as a preoperative test (INOP Test I): the INOP test study group. Circulation 106:I76\u2013I81","journal-title":"Circulation"},{"key":"1818_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2016) 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67\u2013119","journal-title":"Eur Heart J"},{"key":"1818_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/heart.85.1.113","volume":"85","author":"JL Wilkinson","year":"2001","unstructured":"Wilkinson JL (2001) Haemodynamic calculations in the catheter laboratory. Heart 85:113\u2013120","journal-title":"Heart"},{"key":"1818_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0002-9149(03)00991-3","volume":"92","author":"O Hallioglu","year":"2003","unstructured":"Hallioglu O, Dilber E, Celiker A (2003) Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease. Am J Cardiol 92:1007\u20131009","journal-title":"Am J Cardiol"},{"key":"1818_CR14","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/hrt.2010.199661","volume":"96","author":"M D\u2019Alto","year":"2010","unstructured":"D\u2019Alto M, Romeo E, Argiento P, Santoro G, Sarubbi B, Gaio G, M\u00e9lot C, Russo MG, Naeije R, Calabr\u00f2 R (2010) Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy. Heart 96:1475\u20131479","journal-title":"Heart"},{"key":"1818_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.109.883876","volume":"121","author":"K Dimopoulos","year":"2010","unstructured":"Dimopoulos K, Inuzuka R, Goletto S, Giannakoulas G, Swan L, Wort SJ, Gatzoulis MA (2010) Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 121:20\u201325","journal-title":"Circulation"},{"issue":"11","key":"1818_CR16","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurheartj\/eht072","volume":"35","author":"A Manes","year":"2014","unstructured":"Manes A, Palazzini M, Leci E, Bacchi Reggiani ML, Branzi A, Gali\u00e8 N (2014) Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J 35(11):716\u2013724","journal-title":"Eur Heart J"},{"issue":"Suppl 2","key":"1818_CR17","doi-asserted-by":"publisher","first-page":"ii23","DOI":"10.1136\/heartjnl-2014-307340","volume":"102","author":"C Apitz","year":"2016","unstructured":"Apitz C, Hansmann G, Schranz D (2016) Hemodynamic assessment and acute pulmonary vasoreactivity testing in the evaluation of children with pulmonary vascular disease: expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension: the European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart 102(Suppl 2):ii23\u2013ii29","journal-title":"Heart"},{"issue":"23","key":"1818_CR18","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","volume":"31","author":"H Baumgartner","year":"2010","unstructured":"Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E (2010) Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG): ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 31(23):2915\u20132957","journal-title":"Eur Heart J"},{"issue":"23","key":"1818_CR19","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/j.jacc.2008.10.001","volume":"52","author":"CA Warnes","year":"2008","unstructured":"Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Page RL, Riegel B, Tarkington LG, Yancy CW; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease); American Society of Echocardiography; Heart Rhythm Society; International Society for Adult Congenital Heart Disease; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons (2008) ACC\/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52(23):e143\u2013e263","journal-title":"J Am Coll Cardiol"},{"key":"1818_CR20","first-page":"325","volume":"5","author":"C Tissot","year":"2009","unstructured":"Tissot C, Beghetti M (2009) Review of inhaled iloprost for the control of pulmonary artery hypertension in children. Vasc Health Risk Manag 5:325\u2013331","journal-title":"Vasc Health Risk Manag"},{"key":"1818_CR21","doi-asserted-by":"publisher","first-page":"56S","DOI":"10.1016\/j.jacc.2004.02.036","volume":"43","author":"DB Badesch","year":"2004","unstructured":"Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O et al (2004) Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 43:56S\u201361S","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1818_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/eurheartj\/eht437","volume":"35","author":"K Dimopoulos","year":"2014","unstructured":"Dimopoulos K, Wort SJ, Gatzoulis MA (2014) Pulmonary hypertension related to congenital heart disease: a call for action. Eur Heart J 35(11):691\u2013700","journal-title":"Eur Heart J"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-018-1818-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-1818-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-1818-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T23:18:02Z","timestamp":1660432682000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-018-1818-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,9]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["1818"],"URL":"https:\/\/doi.org\/10.1007\/s00246-018-1818-7","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,9]]},"assertion":[{"value":"11 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Hong Gu, Qiangqiang Li, Chen Zhang, Yan Zhu, and Qian Liu have no conflict of interest. Konstantinos Dimopoulos has received unrestricted educational and research funds and has acted as a Consultant for Actelion, GSK, MSD, and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}